MacroGenics Market Cap 2012-2020 | MGNX

MacroGenics market cap history and chart from 2012 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. MacroGenics market cap as of November 24, 2020 is $1.26B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.263B $0.064B
MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $196.537B 35.20
Medtronic (MDT) Ireland $148.079B 27.89
Stryker (SYK) United States $87.507B 32.75
Boston Scientific (BSX) United States $48.256B 28.32
Lonza Group Ag (LZAGY) Switzerland $47.243B 0.00
Baxter (BAX) United States $39.343B 23.63
ResMed (RMD) United States $30.580B 41.38
Zimmer Biomet Holdings (ZBH) United States $30.250B 24.90
Terumo (TRUMY) Japan $29.963B 38.30
EssilorLuxottica Societe Anonyme (ESLOY) France $29.837B 0.00
Sunny Optical Technology (SNPTF) China $22.266B 0.00
Insulet (PODD) United States $17.487B 602.82
Smith & Nephew SNATS (SNN) United Kingdom $17.146B 0.00
Bio-Rad Laboratories (BIO) United States $17.003B 64.48
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
GN STORE NORD (GNNDY) Denmark $10.367B 52.84
DiaSorin S.p.A (DSRLF) Italy $10.238B 0.00
Canopy Growth (CGC) Canada $8.825B 0.00
William Demant Holdings (WILYY) Denmark $8.605B 0.00
Quidel (QDEL) United States $7.875B 19.62
Perrigo (PRGO) Ireland $6.567B 11.56
Hill-Rom Holdings (HRC) United States $6.514B 17.63
Haemonetics (HAE) United States $5.878B 42.72
Envista Holdings (NVST) United States $4.626B 31.16
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.995B 0.00
TG Therapeutics (TGTX) United States $3.925B 0.00
ICU Medical (ICUI) United States $3.896B 29.24
GW Pharmaceuticals (GWPH) United Kingdom $3.875B 0.00
Neogen (NEOG) United States $3.867B 63.39
National Vision Holdings (EYE) United States $3.522B 92.49
Agios Pharmaceuticals (AGIO) United States $3.019B 0.00
DFB Healthcare Acquisitions (AHCO) United States $2.687B 136.27
NuVasive (NUVA) United States $2.364B 34.15
NanoString Technologies (NSTG) United States $2.115B 0.00
AtriCure (ATRC) United States $1.912B 0.00
Aphria (APHA) Canada $1.770B 0.00
Owens & Minor (OMI) United States $1.711B 18.05
Quanterix (QTRX) United States $1.458B 0.00
Cardiovascular Systems (CSII) United States $1.384B 0.00
InMode (INMD) Israel $1.375B 30.93
BioLife Solutions (BLFS) United States $1.061B 1080.67
Cerus (CERS) United States $1.041B 0.00
Aurora Cannabis (ACB) Canada $0.993B 0.00
OraSure Technologies (OSUR) United States $0.867B 0.00
BellRing Brands (BRBR) United States $0.844B 35.67
Lantheus Holdings (LNTH) United States $0.837B 14.89
PetIQ (PETQ) United States $0.819B 46.77
Meridian Bioscience (VIVO) United States $0.814B 17.76
Phibro Animal Health (PAHC) United States $0.777B 16.56
LeMaitre Vascular (LMAT) United States $0.768B 40.59
Omeros (OMER) United States $0.705B 0.00
Vapotherm (VAPO) United States $0.669B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.609B 43.27
Varex Imaging (VREX) United States $0.577B 164.00
Surmodics (SRDX) United States $0.506B 310.08
Zynex (ZYXI) United States $0.466B 43.29
Cytosorbents (CTSO) United States $0.388B 0.00
Viemed Healthcare (VMD) United States $0.358B 12.72
HEXO (HEXO) $0.347B 0.00
Surface Oncology (SURF) United States $0.323B 0.00
Utah Medical Products (UTMD) United States $0.312B 28.50
InfuSystems Holdings (INFU) United States $0.303B 42.71
Organigram Holdings (OGI) Canada $0.260B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.257B 0.00
Bovie Medical (APYX) United States $0.232B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.215B 0.00
Wound Management Technologies (SMTI) United States $0.212B 0.00
Female Health (VERU) United States $0.212B 0.00
Chimerix (CMRX) United States $0.209B 0.00
Exagen (XGN) United States $0.186B 0.00
Evolus (EOLS) United States $0.135B 0.00
Fonar (FONR) United States $0.130B 19.08
Liberty Health Sciences (LHSIF) United States $0.121B 0.00
Chembio Diagnostics (CEMI) United States $0.102B 0.00
Rockwell Medical (RMTI) United States $0.090B 0.00
Capricor Therapeutics (CAPR) United States $0.088B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.086B 0.00
Trinity Biotech (TRIB) Ireland $0.069B 5.30
Brainsway (BWAY) Israel $0.066B 0.00
United-Guardian (UG) United States $0.065B 15.83
Oramed Pharmaceuticals (ORMP) United States $0.063B 0.00
MTech Acquisition (KERN) United States $0.062B 0.00
Nephros (NEPH) United States $0.058B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Myomo (MYO) United States $0.026B 0.00
NF Energy Saving (BIMI) China $0.020B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.020B 0.00
GUARDION HEALTH (GHSI) United States $0.020B 0.00
FSD PHARMA INC (HUGE) Canada $0.018B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Senestech (SNES) United States $0.006B 0.00